- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04907942
Feasibility and Acceptability of Click's EMA and Text Message Intervention for STRESS Management (FACE Stress)
Feasibility and Acceptability of Click's Ecological Momentary Assessment (EMA) and Text Message Intervention for STRESS Management (FACE STRESS Study)
The purpose of this study is to evaluate feasibility and acceptability of an Ecological Momentary Assessment (EMA) compared with an EMA plus automated text message intervention for stress management in participants with higher-than-average perceived stress conducted in a remote setting.
Study details include:
Study Duration: 7 months Intervention Duration: 3 weeks
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- Phase 2
- La phase 1
Contacts et emplacements
Lieux d'étude
-
-
New York
-
New York, New York, États-Unis, 10013
- Click Therapeutics
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age 22 years or older
- Must reside in an Eastern Standard Time or Central Standard Time zone
- Able to read and write in English as demonstrated by review and completion of an Informed Consent Form
- Own an SMS enabled smartphone
- Scoring >5 on the 4-item Perceived Stress Scale (reflecting higher-than-average perceived stress)
Exclusion Criteria:
- Reported cognitive impairment and/or psychiatric disorders of the psychotic spectrum
- Enrolled in another support study
- Currently receiving psychotherapy through telehealth
- PHQ-9 score of 20 or greater.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Comparateur actif: EMA Alone
3 weeks of EMA, consisting of 2 surveys per day delivered via text message and email during waking hours to prompt participants to complete the survey.
|
Three weeks of EMA consisting of 2 daily surveys per day delivered during waking hours to evaluate momentary affects.
|
Expérimental: EMA + Automated Text Message Intervention
|
Intervention includes 3 weeks of EMA (2 daily surveys per day delivered during waking hours to evaluate momentary affects) plus 2 weeks of automated text messages delivered twice a day, which content follows constructs from The Transactional Model of Stress and Coping.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).
Délai: 1 Month
|
Feasibility assessed as the proportion of individuals who contacted us because they are interested in participating
|
1 Month
|
The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).
Délai: 1 Month
|
Feasibility assessed by the number of eligible individuals after the initial screening
|
1 Month
|
The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).
Délai: 1 Month
|
Feasibility assessed by the time taken to recruit the sample
|
1 Month
|
The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).
Délai: 1 Month
|
Feasibility assessed by calculating the retention rates
|
1 Month
|
The main outcome of the FACE STRESS study is to evaluate feasibility of an EMA and EMA plus text message intervention (EMA+).
Délai: 1 Month
|
Feasibility assessed by the number of participants responding to any EMA text over the 3-week study
|
1 Month
|
The main outcome of the FACE STRESS study is to evaluate acceptability of an EMA and EMA plus text message intervention (EMA+).
Délai: 1 Month
|
Acceptability (satisfaction/utility) by using open-ended questions/patient interviews
|
1 Month
|
The main outcome of the FACE STRESS study is to evaluate acceptability of an EMA and EMA plus text message intervention (EMA+).
Délai: 1 Month
|
Acceptability assessed by Likert-scales
|
1 Month
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Ecological Momentary Change in Affects
Délai: 3 Weeks
|
Changes in Momentary Affects will be measured by using Ecological Momentary Assessments delivered twice a day for 3 weeks.
|
3 Weeks
|
Changes in Perceived Stress
Délai: 7 Months
|
Changes in perceived stress will be measured by using the Perceived Stress Scale at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Symptoms of Anxiety
Délai: 7 Months
|
Symptoms of Anxiety will be measured by using the Generalized Anxiety Disorder-7 item scale (GAD-7) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Symptoms of Depression
Délai: 7 Months
|
Change in depression will be measured by using the Patient Health Questionnaire (PHQ-9) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Symptoms of PTSD
Délai: 7 Months
|
Changes in PTSD will be measured by using the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Change in Resilience
Délai: 7 Months
|
Changes in resilience will be measured by using the Brief Resilience Scale (BRS) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Psychological Well-being
Délai: 7 Months
|
Changes in psychological well-being will be measured by using the Euthymia Scale at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Loneliness
Délai: 7 Months
|
Changes in perceived loneliness will be measured by a single question (item) at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Self-Mastery
Délai: 7 Months
|
Changes in self-mastery will be measured by using the Pearlin Self-Mastery Scale at Baseline, 3 weeks post-intervention, and at 1/3/6 month follow-up.
|
7 Months
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- DL-FACE-101
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Covid19
-
Ricardo Pereira MestreInstitute of Oncology Research (IOR); Istituto Cantonale di PatologiaComplété
-
Instituto de Investigación Hospital Universitario...Instituto de Salud Carlos III; Spanish Clinical Research Network - SCReNActif, ne recrute pas
-
Inmunova S.A.Hospital Italiano de Buenos Aires; Laboratorio Elea Phoenix S.A.; Hospital de... et autres collaborateursComplété
-
Manchester University NHS Foundation TrustUniversity of ManchesterComplété
-
Rush University Medical CenterHospital Civil de GuadalajaraComplétéCovid19États-Unis, Mexique
-
Evelyne D.TrottierComplété
-
Sinovac Research and Development Co., Ltd.Complété
-
Mabwell (Shanghai) Bioscience Co., Ltd.Shanghai Public Health Clinical CenterComplété
-
Anavasi DiagnosticsPas encore de recrutement
Essais cliniques sur EMA Alone
-
Northeastern UniversityNational Center for Advancing Translational Sciences (NCATS)ComplétéAphasie acquiseÉtats-Unis
-
Massachusetts General HospitalBoston UniversityRecrutementLa schizophrénie | PsychoseÉtats-Unis
-
The University of Hong KongRecrutement
-
University Hospital, MontpellierCentre Hospitalier Universitaire de Nīmes; Instituto de Investigación Sanitaria... et autres collaborateursRecrutementIdéation suicidaire | Comportement suicidaire | Antécédents personnels d'une crise suicidaire récenteFrance, Espagne
-
Hôpital le VinatierInstitut National de la Santé Et de la Recherche Médicale, FrancePas encore de recrutementDépendance au jeu
-
Chestnut Health SystemsNational Institute on Drug Abuse (NIDA)ComplétéRécupération | Trouble lié à l'utilisation de substances (SUD)États-Unis
-
University of OklahomaRecrutementCancer de la tête et du couÉtats-Unis
-
Temple UniversityAlbert Einstein Healthcare Network; Eunice Kennedy Shriver National Institute... et autres collaborateursRecrutementBlessures à la moelle épinièreÉtats-Unis
-
University of ZurichRadboud University Medical Center; Universitaire Ziekenhuizen KU Leuven; Johannes...Complété
-
Butler HospitalRecrutement